Accord Logo

Intended for UK patients and members of the public

Co-codamol 30/500mg Tablets

Co-codamol 30/500mg Tablets

PL Number:
0142/1308
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Update to SPC sections 4.2, 4.4, 4.8 and PIL in line with PSUSA/00000851/202503 recommendations for Interactions with gabapentinoids, Sphincter of Oddi dysfunction, Hyperalgesia, Central Sleep apnoea (CSA), Opioid drug disorder (OUD), and the need to store the product in a safe and secure place.

    MHRA recommendations for Opioid use disorder (OUD) in codeine/paracetamol combination products is to align with the PSUSA recommendations.

    Additional editorial amends made in SPC and PIL.

    PIL sections updated: 2, 3, 4, 5 and 6

    Approval date: 09/04/2026

  • Update to SPC sections 4.2, 4.4, 4.8 and PIL in line with PSUSA/00000851/202503 recommendations for Interactions with gabapentinoids, Sphincter of Oddi dysfunction, Hyperalgesia, Central Sleep apnoea (CSA), Opioid drug disorder (OUD), and the need to store the product in a safe and secure place.

    MHRA recommendations for Opioid use disorder (OUD) in codeine/paracetamol combination products is to align with the PSUSA recommendations.

    Additional editorial amends made in SPC and PIL.

    SPC sections updated: 4.2, 4.4, 4.8 and 10

    Approval date: 09/04/2026

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

For any further assistance, please get in touch.

View product information as a: